SG11201601262QA - CELL CULTURE MEDIUM AND PROCESS FOR CONTROLLING α-AMIDATION AND/OR C-TERMINAL AMINO ACID CLEAVAGE OF POLYPEPTIDES - Google Patents
CELL CULTURE MEDIUM AND PROCESS FOR CONTROLLING α-AMIDATION AND/OR C-TERMINAL AMINO ACID CLEAVAGE OF POLYPEPTIDESInfo
- Publication number
- SG11201601262QA SG11201601262QA SG11201601262QA SG11201601262QA SG11201601262QA SG 11201601262Q A SG11201601262Q A SG 11201601262QA SG 11201601262Q A SG11201601262Q A SG 11201601262QA SG 11201601262Q A SG11201601262Q A SG 11201601262QA SG 11201601262Q A SG11201601262Q A SG 11201601262QA
- Authority
- SG
- Singapore
- Prior art keywords
- amidation
- polypeptides
- controlling
- amino acid
- culture medium
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0018—Culture media for cell or tissue culture
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/241—Tumor Necrosis Factors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/05—Inorganic components
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/05—Inorganic components
- C12N2500/10—Metals; Metal chelators
- C12N2500/20—Transition metals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/05—Inorganic components
- C12N2500/10—Metals; Metal chelators
- C12N2500/20—Transition metals
- C12N2500/22—Zinc; Zn chelators
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Enzymes And Modification Thereof (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP13181027 | 2013-08-20 | ||
| PCT/EP2014/067762 WO2015024977A1 (fr) | 2013-08-20 | 2014-08-20 | Milieux de culture cellulaire et procédé pour réguler l'α-amidation et/ou le clivage d'acides aminés c-terminaux de polypeptides |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201601262QA true SG11201601262QA (en) | 2016-03-30 |
Family
ID=48986049
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201601262QA SG11201601262QA (en) | 2013-08-20 | 2014-08-20 | CELL CULTURE MEDIUM AND PROCESS FOR CONTROLLING α-AMIDATION AND/OR C-TERMINAL AMINO ACID CLEAVAGE OF POLYPEPTIDES |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US10196601B2 (fr) |
| EP (1) | EP3036254A1 (fr) |
| JP (1) | JP2016527911A (fr) |
| KR (1) | KR102118240B1 (fr) |
| CN (1) | CN105473614B (fr) |
| AU (1) | AU2014310555B2 (fr) |
| BR (1) | BR112016002622B1 (fr) |
| CA (1) | CA2915948A1 (fr) |
| SG (1) | SG11201601262QA (fr) |
| WO (1) | WO2015024977A1 (fr) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2702077A2 (fr) | 2011-04-27 | 2014-03-05 | AbbVie Inc. | Procédé de contrôle du profil de galactosylation de protéines exprimées de manière recombinante |
| US9067990B2 (en) | 2013-03-14 | 2015-06-30 | Abbvie, Inc. | Protein purification using displacement chromatography |
| WO2013158279A1 (fr) | 2012-04-20 | 2013-10-24 | Abbvie Inc. | Procédés de purification de protéines pour réduire des espèces acides |
| US9181572B2 (en) | 2012-04-20 | 2015-11-10 | Abbvie, Inc. | Methods to modulate lysine variant distribution |
| US9512214B2 (en) | 2012-09-02 | 2016-12-06 | Abbvie, Inc. | Methods to control protein heterogeneity |
| US9017687B1 (en) | 2013-10-18 | 2015-04-28 | Abbvie, Inc. | Low acidic species compositions and methods for producing and using the same using displacement chromatography |
| WO2014151878A2 (fr) | 2013-03-14 | 2014-09-25 | Abbvie Inc. | Procédés pour la modulation des profils de glycosylation de protéines de traitements à base de protéines recombinantes au moyen de monosaccharides et d'oligosaccharides |
| EP3052640A2 (fr) | 2013-10-04 | 2016-08-10 | AbbVie Inc. | Utilisation d'ions métaux pour la modulation des profils de glycosylation de protéines recombinantes |
| US9181337B2 (en) | 2013-10-18 | 2015-11-10 | Abbvie, Inc. | Modulated lysine variant species compositions and methods for producing and using the same |
| US9085618B2 (en) | 2013-10-18 | 2015-07-21 | Abbvie, Inc. | Low acidic species compositions and methods for producing and using the same |
| WO2015073884A2 (fr) | 2013-11-15 | 2015-05-21 | Abbvie, Inc. | Compositions de protéines de liaison génétiquement glycomodifiées |
| AR104050A1 (es) * | 2015-03-26 | 2017-06-21 | Chugai Pharmaceutical Co Ltd | Proceso de producción con iones de cobre controlados |
| TW201923069A (zh) * | 2017-10-02 | 2019-06-16 | 美商拜耳保健有限責任公司 | 以亞硒酸鹽防止細胞培養收獲物中雙硫鍵還原之方法 |
| CN117018164B (zh) * | 2023-06-19 | 2024-06-07 | 广东源心再生医学有限公司 | Cpon的应用 |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ210501A (en) | 1983-12-13 | 1991-08-27 | Kirin Amgen Inc | Erythropoietin produced by procaryotic or eucaryotic expression of an exogenous dna sequence |
| GB2220938B (en) | 1988-07-20 | 1992-01-29 | Erba Carlo Spa | Use of pam enzyme in solid phase peptide synthesis |
| GB2233978B (en) * | 1989-07-17 | 1993-03-03 | Erba Carlo Spa | Cofactors for enzymatic amidation |
| GB8916289D0 (en) | 1989-07-17 | 1989-08-31 | Erba Carlo Spa | Cofactor for the pam enzyme |
| EP0779362B2 (fr) | 1989-12-22 | 2012-06-13 | Laboratoires Serono SA | Constructions de type ADN pour l'activation et la modification de l'expression de gènes endogènes |
| NZ245015A (en) | 1991-11-05 | 1995-12-21 | Transkaryotic Therapies Inc | Delivery of human growth hormone through the administration of transfected cell lines encoding human growth hormone, which are physically protected from host immune response; the transfected cells and their production |
| US5723765A (en) | 1994-08-01 | 1998-03-03 | Delta And Pine Land Co. | Control of plant gene expression |
| KR100302100B1 (ko) | 1999-05-03 | 2001-11-22 | 박찬구 | 고무입자-결합 단백질(ｓｒｐｐ)을 발현하는 재조합 미생물 |
| CN1114619C (zh) * | 1999-06-25 | 2003-07-16 | 中国科学院上海细胞生物学研究所 | 小鼠杂交瘤株Hepama－1分泌的肝癌鼠源单克隆抗体的制备方法 |
| US8227241B2 (en) | 2004-03-12 | 2012-07-24 | Unigene Laboratories, Inc. | Bacterial host cell for the direct expression of peptides |
| WO2005100573A2 (fr) | 2004-04-16 | 2005-10-27 | Dsm Ip Assets B.V. | Promoteurs fongiques destines a l'expression d'un gene dans une cellule fongique |
| US20050287666A1 (en) * | 2004-06-29 | 2005-12-29 | Invitrogen Corporation | Cell culture medium comprising transition metals or trace elements |
| KR101495549B1 (ko) * | 2006-07-13 | 2015-02-25 | 와이어쓰 엘엘씨 | 당단백질의 생산 |
| AU2008223133A1 (en) * | 2007-03-02 | 2008-09-12 | Wyeth | Use of copper and glutamate in cell culture for production of polypeptides |
| CN100482786C (zh) * | 2007-12-28 | 2009-04-29 | 天津百若克医药生物技术有限责任公司 | 一种人胚肾293细胞扩增无蛋白培养基 |
| US20110143432A1 (en) * | 2008-06-09 | 2011-06-16 | AS Vahiuuringute Tehnoloogia Arenduskekus | Use of extract of selenium-enriched yeast (se-ye) in mammalian cell culture media formulations |
| KR101030978B1 (ko) | 2008-07-10 | 2011-04-28 | (주) 에이프로젠 | 동물세포용 재조합 발현벡터 |
| EP2516404A4 (fr) | 2009-12-23 | 2013-04-17 | Reddys Lab Ltd Dr | Préparation de la bendamustine et de ses sels |
| EP2560479A4 (fr) | 2010-04-22 | 2014-01-01 | Senesco Technologies Inc | Algues transgéniques permettant une extraction par pression améliorée |
| ES2533074T3 (es) | 2010-04-26 | 2015-04-07 | Novartis Ag | Medio de cultivo celular mejorado |
| EP2450375A1 (fr) | 2010-11-09 | 2012-05-09 | Sandoz Gmbh | Milieu de culture cellulaire et procédé pour l'expression de protéines, ledit milieu et ledit procédé comprenant un inhibiteur de PAM |
| WO2013156458A1 (fr) | 2012-04-16 | 2013-10-24 | Lek Pharmaceuticals D.D. | Réduction de la formation d'acides aminés amidés dans des lignées cellulaires pour l'extraction protéique |
| US9181572B2 (en) * | 2012-04-20 | 2015-11-10 | Abbvie, Inc. | Methods to modulate lysine variant distribution |
| MX366910B (es) | 2013-03-15 | 2019-07-30 | Janssen Biotech Inc | Metodos de fabricacion para controlar el contenido de lisina c-terminal, galactosa y acido sialico en proteinas recombinantes. |
-
2014
- 2014-08-20 BR BR112016002622-5A patent/BR112016002622B1/pt active IP Right Grant
- 2014-08-20 EP EP14752892.1A patent/EP3036254A1/fr not_active Withdrawn
- 2014-08-20 JP JP2016535474A patent/JP2016527911A/ja active Pending
- 2014-08-20 SG SG11201601262QA patent/SG11201601262QA/en unknown
- 2014-08-20 CA CA2915948A patent/CA2915948A1/fr not_active Abandoned
- 2014-08-20 AU AU2014310555A patent/AU2014310555B2/en active Active
- 2014-08-20 CN CN201480046012.6A patent/CN105473614B/zh active Active
- 2014-08-20 KR KR1020167005093A patent/KR102118240B1/ko active IP Right Grant
- 2014-08-20 US US14/913,312 patent/US10196601B2/en active Active
- 2014-08-20 WO PCT/EP2014/067762 patent/WO2015024977A1/fr active Application Filing
Also Published As
| Publication number | Publication date |
|---|---|
| KR102118240B1 (ko) | 2020-06-03 |
| CN105473614A (zh) | 2016-04-06 |
| AU2014310555A1 (en) | 2016-03-10 |
| BR112016002622A2 (pt) | 2017-08-01 |
| EP3036254A1 (fr) | 2016-06-29 |
| US20160201028A1 (en) | 2016-07-14 |
| JP2016527911A (ja) | 2016-09-15 |
| AU2014310555B2 (en) | 2018-01-18 |
| KR20160036612A (ko) | 2016-04-04 |
| CN105473614B (zh) | 2019-11-01 |
| BR112016002622B1 (pt) | 2023-04-11 |
| US10196601B2 (en) | 2019-02-05 |
| WO2015024977A1 (fr) | 2015-02-26 |
| CA2915948A1 (fr) | 2015-02-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG11201601262QA (en) | CELL CULTURE MEDIUM AND PROCESS FOR CONTROLLING α-AMIDATION AND/OR C-TERMINAL AMINO ACID CLEAVAGE OF POLYPEPTIDES | |
| HRP20190484T1 (hr) | Pripravci stanične kulture i postupci proizvodnje polipeptida | |
| IL248361B (en) | Recombinant host cell for expression of desired proteins | |
| SG10201607968WA (en) | Artificial nucleic acid molecules for improved protein or peptide expression | |
| MY173953A (en) | Recombinant host cells for the production of malonate | |
| PL3036320T3 (pl) | Kontrola glikozylacji białka poprzez parametry procesu suplementacji pożywki hodowlanej i hodowli komórkowej | |
| EP3210997C0 (fr) | Agents et procédés pour l'expression et la sécrétion de peptides et de protéines | |
| PL2986633T3 (pl) | Sposoby ekspresji peptydów i białek | |
| EP3448884C0 (fr) | Cellules de mammifères modifiées pour la production de protéines recombinantes | |
| HK1205186A1 (en) | Method for the expression of polypeptides using modified nucleic acids | |
| HK1197265A1 (en) | Method for highly expressing recombinant protein of engineering bacteria and use thereof | |
| HUE063273T2 (hu) | Heteromultimer fehérjék elõállítása emlõssejtek felhasználásával | |
| EP3064576A4 (fr) | Composition de polypeptide et procédé de culture de cellules souches pluripotentes l'utilisant | |
| PT2804875T (pt) | Ferramentas e métodos para expressão de proteínas de membrana | |
| EP3088415A4 (fr) | Procédé d'induction de la différenciation de cellules souches pluripotentes en cellules de l'endoderme | |
| SI2839003T1 (sl) | Zmanjšanje tvorbe amidiranih aminokislin v celičnih linijah za izražanje proteinov | |
| HK1221977A1 (zh) | 用於產生供生產重組蛋白的哺乳動物生產細胞的物品和方法 | |
| SG11201506342XA (en) | Culture medium for growth of recombinant proteins | |
| IL235052B (en) | A method for increasing the secretion of recombinant proteins | |
| KR101737796B9 (ko) | 피더 비의존적 인간 전분화능줄기세포 배양방법 | |
| EP3045531A4 (fr) | Procédé permettant d'induire la différenciation de cellules souches pluripotentes induites et procédé permettant de sélectionner des cellules souches pluripotentes induites | |
| EP3058362A4 (fr) | Méthode in vitro pour la détermination du devenir d'un variant polypeptidique |